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e report the characterization of the dominant-
negative 
 
CLA4t
 
 allele of the budding yeast 
 
CLA4
 
gene, encoding a member of the p21-activated
kinase (PAK) family of protein kinases, which, together
with its homologue 
 
STE20
 
, plays an essential role in pro-
moting budding and cytokinesis. Overproduction of the
Cla4t protein likely inhibits both endogenous Cla4 and
Ste20 and causes a delay in the onset of anaphase that
correlates with inactivation of Cdc20/anaphase-promoting
complex (APC)–dependent proteolysis of both the cyclinB
Clb2 and securin. Although the precise mechanism of APC
W
 
inhibition by Cla4t remains to be elucidated, our results
suggest that Cla4 and Ste20 may regulate the ﬁrst wave of
cyclinB proteolysis mediated by Cdc20/APC, which has
been shown to be crucial for activation of the mitotic exit
network (MEN). We show that the Cdk1-inhibitory kinase
Swe1 is required for the Cla4t-dependent delay in cell cycle
progression, suggesting that it might be required to prevent
full Cdc20/APC and MEN activation. In addition, inhibition
of PAK kinases by Cla4t prevents mitotic exit also by a
Swe1-independent mechanism impinging directly on the
MEN activator Tem1.
 
Introduction
 
In eukaryotic cells, entry into mitosis is driven by both acti-
vation of cyclinB-dependent Cdks and ubiquitin-dependent
proteolysis triggered by the ubiquitin–ligase anaphase-
promoting  complex (APC).* At the metaphase–anaphase
transition, the APC targets the Esp1 separase inhibitor securin
for degradation, leading in turn to cleavage of the bonds
between sister chromatids (Peters, 2002). APC-dependent
proteolysis is also required at the end of mitosis to promote
mitotic exit and cytokinesis. In particular, degradation of
B-type cyclins seems to be crucial for Cdk inactivation, leading
to spindle disassembly, cytokinesis, and entry into a new
round of DNA replication (Zachariae and Nasmyth, 1999). To
display full ubiquitin–ligase activity, the APC must bind to
the Cdc20 and Cdh1 accessory factors that are responsible for
securin and cyclinB degradation, respectively (Peters, 2002).
As in other eukaryotic systems, the onset of anaphase in
budding yeast requires activation of the Cdk Cdc28 bound
to any of four mitotic B-type cyclins, Clb1–4. Although the
role of Clb1–4/Cdc28 kinases during this cell cycle transition
can be attributed primarily to their essential function in
spindle assembly (Surana et al., 1991; Fitch et al., 1992),
some evidence suggests that they also stimulate the binding
between Cdc20 and APC, thereby allowing mitotic exit
(Rudner et al., 2000; Rudner and Murray, 2000). In this
way, at the onset of anaphase, Clb1–4/Cdc28 kinases sow
the seeds for their own destruction.
Work in budding yeast has shown that the Cdc14 protein
phosphatase is critical to inactivate cyclinB/Cdks at the end
of mitosis by dephosphorylating and activating both Cdh1
and the cyclinB/Cdk inhibitor Sic1 (Visintin et al., 1998).
Cdc14 must be released from the nucleolus in order to be
active during mitotic exit, and this requires a signal trans-
duction cascade called mitotic exit network (MEN), involving
the Tem1 GTPase, its GTPase exchange factor Lte1, several
protein kinases and associated factors (Cdc5, Cdc15, Mob1/
Dbf2, Dbf20), and a scaffold protein (Nud1; Bardin and
Amon, 2001; Geymonat et al., 2002). Recently, an early
anaphase release of Cdc14 from the nucleolus has been
shown to be transiently driven by the Polo kinase Cdc5 and
separase independently of the MEN, and to contribute to
full MEN activation, thus generating a positive feedback
loop (Pereira et al., 2002; Stegmeier et al., 2002; Yoshida et
al., 2002).
Although Cdc20/APC reaches its maximal activity at the
onset of anaphase, it is also necessary for inactivation of cyclinB/
Cdks at the end of mitosis in different ways: (1) by triggering
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securin degradation, which in turn promotes separase activa-
tion and Cdc14 early release from the nucleolus; (2) by pro-
moting degradation of the S-phase cyclin Clb5, whose asso-
ciated Cdk activity prevents Cdc14 activation (Shirayama et
al., 1999); and (3) by inducing directly a first wave of cy-
clinB degradation during anaphase (Baumer et al., 2000;
Yeong et al., 2000), which is important for subsequent Cdh1
and MEN activation. Furthermore, a recent report has chal-
lenged the current view on mitotic exit regulation by high-
lighting the essential role of Cdc20/APC-driven degradation
of the mitotic cyclin Clb2 (Wasch and Cross, 2002).
To ensure faithful chromosome transmission and genomic
stability, progression through mitosis is tightly regulated by
surveillance mechanisms (called checkpoints) that prevent or
delay specific cell cycle transitions in response to differ-
ent kinds of injuries, thus allowing correction of errors
(Hartwell and Weinert, 1989). In particular, the metaphase
to anaphase transition can be delayed by checkpoint mecha-
nisms that respond to DNA damage (Weinert et al., 1994),
spindle disassembly/misorientation (Hoyt, 2000; Gorbsky,
2001; Wassmann and Benezra, 2001), or faulty cytoskeletal
organization (Lew, 2000). In budding yeast, the spindle as-
sembly checkpoint is divided in two different branches, one
monitoring kinetochore/microtubule attachment and/or ki-
netochore tension, and the other sensing spindle misposi-
tioning. The kinetochore checkpoint, which involves Mad1,
-2, and -3, Bub1 and -3, Mps1, Ndc10, and Ipl1, leads to
inhibition of Cdc20/APC, thereby preventing both the
anaphase onset and exit from mitosis (for review see Musac-
chio and Hardwick, 2002). Conversely, the spindle position
checkpoint inhibits the Tem1 GTPase at the top of the
MEN through the Bub2/Bfa1 two-component GTPase-acti-
vating protein (GAP), and therefore controls primarily mi-
totic exit and cytokinesis (Hoyt, 2000). Tem1 activation re-
quires either inactivation of the GAP by the Cdc5 Polo
kinase (Hu et al., 2001) or exposure to the GTPase exchange
factor Lte1 (Shirayama et al., 1994). Strikingly, Tem1 re-
sides at SPBs, whereas Lte1 is asymmetrically localized at the
bud cortex, thus coupling spindle pole and nuclear migra-
tion in the bud with mitotic exit (Bardin et al., 2000; Pereira
et al., 2000). Finally, the morphogenesis checkpoint delays
the G2/M transition, specifically in response to perturba-
tions in the actin cytoskeleton or in septin deposition, and
depends on the Swe1-mediated phosphorylation and inacti-
vation of Cdc28 (Lew, 2000).
Whether there are crosstalks between different check-
points and how all the outputs of checkpoint controls are in-
tegrated in order to ensure the right progression of mitotic
events are critical points still under investigation. In this pa-
per, we present data that link cytokinesis, the spindle check-
point, and the morphogenesis checkpoint by describing a
dominant-negative 
 
CLA4
 
 allele (
 
CLA4t
 
) that likely inhibits
both endogenous Cla4 and Ste20. These two proteins share
overlapping essential functions in controlling budding and
cytokinesis (Cvrckova et al., 1995; Holly and Blumer, 1999;
Weiss et al., 2000), and are members of the p21-activated
kinase (PAK) family of protein kinases, which are effectors
of the Cdc42 GTPase, playing a crucial role in regulating
cell polarity in all eukaryotic cells (Johnson, 1999). From
our data, PAK kinases appear to contribute to promote mi-
totic exit by regulating the MEN in two different ways; by
allowing the first burst of cyclinB/Cdk inactivation that oc-
curs at the onset of anaphase, and more directly, by estab-
lishing the conditions for Tem1 activation.
 
Results
 
High copy number of a truncated 
 
CLA4
 
 gene can 
suppress the benomyl sensitivity of spindle 
checkpoint mutants
 
To gain insights into the Bub2/Bfa1 signal transduction cas-
cade, we screened a budding yeast genomic library for high
dosage suppressors of the sensitivity of a 
 
bub2
 
 
 
 mutant to
the microtubule-depolymerizing drug benomyl (see Materi-
als and methods). Among the isolated clones, we found a
plasmid carrying the whole promoter region and 92% of the
 
CLA4
 
 coding sequence (
 
CLA4t
 
). The Cla4t protein lacks 67
amino acids at its COOH-terminal region, where the essen-
tial kinase domain resides, but retains unaltered pleckstrin
homology and PAK domains, the latter being involved in
the association with Cdc42 (Benton et al., 1997; Fig. 1 A).
Subcloning of both full-length and truncated 
 
CLA4
 
 in the
YEp13 2
 
 
 
 vector revealed that only high copy number
 
CLA4t
 
 can suppress the benomyl sensitivity of 
 
bub2
 
 
 
, al-
though to a lesser extent than wild-type 
 
BUB2
 
 (Fig. 1 B).
Moreover, 2
 
 
 
 
 
CLA4t
 
 could also suppress the benomyl sensi-
tivity of other spindle checkpoint mutants, like 
 
mad2
 
 
 
 and
 
bfa1
 
 
 
 (Fig. 1 C), but not that of the 
 
 
 
-tubulin mutant
 
tub2–405
 
 (unpublished data), suggesting that the suppres-
sion mechanism might involve differences in cell cycle pro-
gression rather than in microtubule stability.
 
Expression of 
 
CLA4t
 
 suppresses spindle 
checkpoint defects
 
To better control the expression of 
 
CLA4t,
 
 we cloned it un-
der the galactose-inducible 
 
GAL1–10
 
 promoter, and inte-
grated the 
 
GAL-CLA4t
 
 fusion at the 
 
URA3
 
 chromosomal
locus. Galactose-induced expression of 
 
GAL-CLA4t
 
 had a
strong dose effect on growth, with 4X 
 
GAL-CLA4t
 
 inte-
grated copies almost totally inhibiting cells’ ability to form
colonies, whereas a single copy had little effect (Fig. 1 D).
Therefore, we asked whether expression of 
 
GAL-CLA4t
 
 in
 
bub2
 
 
 
, 
 
mad2
 
 
 
, and 
 
mad2
 
 
 
 bub2
 
 
 
 strains could suppress
the checkpoint defects of these mutants. Synchronized G1
cultures of wild-type and the above mutants, either lacking
or carrying a single copy of 
 
GAL-CLA4t
 
, were released in
the presence of galactose and the microtubule-depolymeriz-
ing drug nocodazole, to follow their kinetics of cell cycle
progression by FACS
 
®
 
 analysis (Fig. 2 A). As expected, in
these conditions 
 
bub2
 
 
 
, 
 
mad2
 
 
 
, and 
 
mad2
 
 
 
 bub2
 
 
 
 mu-
tants, unlike the wild-type strain, accumulated cells with
DNA contents higher than 2C and 
 
mad2 bub2
 
 double mu-
tants re-replicated their genome much faster than either sin-
gle mutant, as previously shown (Alexandru et al., 1999;
Fesquet et al., 1999; Fraschini et al., 1999; Li, 1999). Strik-
ingly, expression of 
 
GAL-CLA4t
 
 prevented 
 
bub2
 
 
 
 and
 
mad2
 
 
 
 cells from entering a new round of DNA replication
and restrained also a fraction of 
 
mad2
 
 
 
 bub2
 
 
 
 cells from
doing so.T
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Figure 1. Effects of CLA4t overexpression on benomyl sensitivity and cell growth. (A) Schematic representation of wild-type Cla4 and its 
truncated Cla4t variant. PH, pleckstrin homology domain; PAK, p21-activated kinase family domain. (B and C) Serial dilutions of wild-type 
(W303), bub2  (ySP1071), mad2  (ySP1070), and bfa1  (ySP1243) strains carrying the indicated 2  plasmids were spotted on YEPD plates 
with or without benomyl and incubated for two days at 25 C. (D) Serial dilutions of wild-type (W303) and isogenic strains carrying the 
indicated numbers of integrated GAL-CLAt fusions were spotted on YEPD ( Gal, GAL1 promoter off) and YEPRG ( Gal, GAL1 promoter on) 
plates and incubated for two days at 30 C.T
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Because re-replication in the presence of nocodazole de-
pends on inactivation of cyclinB-dependent Cdks by both
APC-mediated proteolysis of cyclins and accumulation of
Cdk inhibitors, we analyzed the levels of the main mitotic
cyclinB (Clb2) and the Clb/Cdk inhibitor Sic1 in an experi-
ment similar to the one above (Fig. 2 B). Although 
 
bub2
 
 
 
,
Figure 2. GAL-CLA4t expression suppresses the 
spindle checkpoint defects of mad2 and bub2 
mutants. (A) Cultures of wild-type, bub2 , mad2 , 
and mad2  bub2  mutants, either lacking (W303, 
ySP3138, ySP1070, and ySP1086) or carrying one 
integrated copy of GAL-CLA4t (ySP2622, ySP2626, 
ySP2752, and ySP3068) were arrested in G1 by 
 -factor treatment and then released into YEPRG 
medium containing nocodazole (t   0). (B) The 
same strains and procedure as in A were used, but 
10  g/ml  -factor was re-added to all cultures at
t   100’ after release (at least 90% of budded cells) 
to prevent them from entering a new cell cycle. At 
the indicated times cells were collected for FACS
® 
analysis of DNA contents (A) and for Western blot 
analysis of Clb2 and Sic1 protein levels (B). Swi6 
was used as loading control. Cyc, cycling cells.
Figure 2 continues on facing page.T
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mad2
 
 
 
, and 
 
mad2
 
 
 
 bub2
 
 
 
 cells underwent Clb2 proteolysis
in the presence of nocodazole as described previously (Alex-
andru et al., 1999; Fraschini et al., 1999), expression of
 
GAL-CLA4t
 
 in these mutants protected a fraction of Clb2
from degradation. In addition, Cla4t strongly reduced re-
accumulation of Sic1 in 
 
bub2
 
 
 
 cells, but only slightly (if at
all) in 
 
mad2
 
 
 
 and 
 
mad2
 
 
 
 bub2
 
 
 
 cells. This suggests that in
the latter mutants, the phosphatase Cdc14, which promotes
Sic1 transcription and activation (Visintin et al., 1998), might
be active at least for what concerns accumulation of Sic1.
 
CLA4t
 
 inhibits PAK kinases and causes Swe1-dependent 
cell cycle delay
 
To gain insights into the molecular mechanism by which
Cla4t might prevent inactivation of Clb/Cdk1 kinases in
spindle checkpoint mutants, we investigated its effects when
four copies of 
 
GAL-CLA4t
 
 were expressed in otherwise wild-
type cells, where they almost completely inhibit cell prolifer-
ation (Fig. 1 D). Synchronized G1 wild-type cells, either
lacking or carrying four integrated 
 
GAL-CLA4t
 
 copies (4X
 
GAL-CLA4t
 
), were released in the presence of galactose and
analyzed at different time points for DNA contents, kinetics
of nuclear division, and cell morphology. 4X 
 
GAL-CLA4t
 
cells arrested with 2C DNA contents (Fig. 3 A) and undi-
vided nuclei (Fig. 3, B and C), suggesting that not only mi-
totic exit, but also the onset of anaphase, failed to take place.
Indeed, the securin Pds1 was stabilized in these cells (un-
published data), suggesting that Cdc20/APC could be inac-
tive. In addition, cells displayed a dramatic cytokinetic de-
fect due to a failure to form a proper bud neck (Fig. 3 C).
This peanut-shaped cell phenotype closely resembled that
observed after simultaneous inactivation of 
 
CLA4
 
 and
 
STE20
 
 (Cvrckova et al., 1995), suggesting that these two re-
dundant PAK kinases might be inactive in galactose-induced
4X 
 
GAL-CLA4t
 
 cells. In agreement with this hypothesis, a
reduced fraction of these cells was able to assemble or main-
tain a proper septin ring at the bud neck (Fig. 3 E), as shown
by localization of the Cdc3 septin fused to the GFP (Cdc3-
GFP), similarly to what was shown for 
 
cla4 ste20
 
 double
mutants (Cvrckova et al., 1995; Holly and Blumer, 1999).
In addition, overexpression of 
 
GAL-CLA4t
 
 disrupted local-
ization of both myc-tagged Cla4 at the bud tip and myc-
tagged Ste20 on polarized cell surface projections of phero-
mone-treated cells (Fig. 3 F), despite that it did not affect
distribution of cortical actin (unpublished data; see Fig. 6
C). High levels of Cla4t also reduced the ability of endoge-
nous Cla4 to phosphorylate myelin-basic protein in vitro
(Fig. 3 D), suggesting that they could compromise Cla4 ki-T
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nase activity in vivo. Finally, deletion of either CLA4 or
STE20 reduced, but did not abolish, the ability of bub2 
cells to re-replicate in the presence of nocodazole (Fig. 3 G).
We also noticed that the Hsl1 protein kinase, responsible
for targeting the Swe1 kinase to degradation (McMillan et
al., 1999), was localized at the bud neck in virtually all wild-
type budded cells from the onset of budding until late
anaphase, but it was homogeneously distributed throughout
the cells of the 4X GAL-CLA4t strain (Fig. 3 H) and might
thus be inactive. Because deletion of CLA4 was shown to ac-
tivate the morphogenesis checkpoint, resulting in a G2/M
delay due to the Swe1-dependent phosphorylation of Cdc28
(Longtine et al., 2000; Weiss et al., 2000; Mitchell and
Sprague, 2001), we asked whether the cell cycle delay caused
by overproduced Cla4t could also depend on SWE1. In-
deed, deletion of SWE1 allowed synchronized 4X GAL-
CLA4t cells to undergo nuclear division with nearly wild-
type kinetics in the presence of galactose (Fig. 3, B and C),
suggesting that Swe1 is responsible for preventing anaphase
in these cells. Conversely, lack of Swe1 did not rescue their
cytokinetic defects (Fig. 3 C) and was only partially able to
drive them out of mitosis and into a new round of DNA
replication, as shown by the appearance of cells with 4C
DNA contents (Fig. 3 A). Thus, Swe1 restrains mitotic exit
in Cla4t-overproducing cells, but additional mechanisms are
also involved.
Cla4t ability to suppress spindle checkpoint defects 
partially depends on Swe1
The data above indicate that Cla4t high levels delay the
metaphase–anaphase transition in a Swe1-dependent man-
ner, suggesting that Cla4t and Swe1 could prevent the onset
of anaphase by inhibiting more directly the activity of
Cdc20/APC. Therefore, we investigated whether expression
of one copy of GAL-CLA4t, which has only mild effects on
cell proliferation (Fig. 1 D) but suppresses spindle check-
point defects (Fig. 2), might affect Cdc20/APC-dependent
proteolysis of Pds1 and Clb2 during an unperturbed cell cy-
cle. As shown in Fig. 4 A, Pds1 was stabilized in Cla4t ex-
pressing cells, and this correlated with a slight nuclear divi-
sion delay (Fig. 4 B). Cla4t also protected a fraction of Clb2
from degradation, whereas no major effects were found on
the levels of Sic1 accumulation. Thus, Cdc20/APC, which
triggers both Pds1 and Clb2 degradation, might not be fully
active in Cla4t expressing cells. Remarkably, deletion of
SWE1 accelerated proteolysis of both Pds1 and Clb2 in
these cells, although not to wild-type levels (Fig. 4 A), and
restored normal kinetics of nuclear division (Fig. 4 B), sug-
gesting that Swe1 is required for Cla4t to delay the onset of
anaphase. The CDC28
Y19F allele, encoding an unphosphory-
latable Cdc28 protein, had an intermediate effect because it
reduced Pds1 levels but did not rescue the delay in either nu-
clear division or Clb2 degradation. However, we could not
Figure 3 continues on facing page.T
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exclude that Swe1 exerts its inhibitory function through
Cdc28 phosphorylation because our results could be biased
by the fact that the CDC28
Y19F mutant displays, by itself, re-
duced Cdc20/APC activity (Rudner et al., 2000).
Next, we asked whether deletion of SWE1 could also revert
the Cla4t-dependent suppression of spindle checkpoint de-
fects. For this purpose, we analyzed the ability of swe1 
mad2  or swe1  bub2  strains carrying a single copy of GAL-
CLA4t to support Clb2 degradation and Sic1 accumulation, as
well as to re-replicate DNA, on nocodazole treatment. In a
first experiment GAL-CLA4t, mad2 , mad2  GAL-CLA4t,
mad2  swe1  GAL-CLA4t, and mad2  CDC28
Y19F GAL-
Figure 3. CLA4t overexpression inhibits endogenous Cla4 and Ste20 PAK kinases and causes a Swe1-dependent G2/M arrest. (A–C) Wild-type 
(W303), 4X GAL-CLA4t (ySP2625) and swe1  4X GAL-CLA4t (ySP2711) cells were grown in YEPR, arrested in G1 with  -factor and then 
released in YEPRG medium (t   0). Samples were collected at the indicated times for FACS
® analysis of DNA contents (A) and to follow kinetics 
of nuclear division (B). Photographs were taken at t   5 h after release (C). Bar, 5  m. (D) wild-type (ySP3086, lanes 3–6) and 4X GAL-CLA4t 
cells (ySP3088, lanes 7–10), expressing myc-tagged Cla4 (Cla4myc18), as well as an untagged strain (W303, lanes 1 and 2) were grown in 
YEPR (lanes 1, 3, and 7) and then shifted to YEPRG for 2 h (lanes 4 and 8) and 3 h (lanes 5 and 9), or to YEPRG with nocodazole for 2.5 h 
(lanes 2, 6, and 10). Anti-myc immunoprecipitates from the corresponding cell extracts were subjected to Western blot analysis with anti-myc 
antibodies (IP) and to kinase assays using myelin basic protein (MBP) as substrate. (E) Wild-type (W303), 1X GAL-CLA4t (ySP2622) and 4X 
GAL-CLA4t (ySP2625) cells carrying a pRS316 plasmid with a GFP-CDC3 fusion (Vallen et al., 2000) were grown in YEPR and then shifted to 
YEPRG medium. After 3 h, GFP-Cdc3 was scored in unbudded and budded cells (n   500) to monitor the presence of a septin ring. (F) Left; 
wild-type (ySP3086) and 4X GAL-CLA4t (ySP3088) cells, expressing Cla4myc18, were grown in YEPR, arrested in G1 with  -factor, and released 
in YEPRG (t   0). Samples were collected every 10 min for 2 h for FACS
® analysis of DNA contents (not depicted) and immunostaining of 
Cla4myc18. Photographs were taken at t   50’, when wild-type cells reached a peak of small budded cells with cortical Cla4myc18 (30% of 
total cells). The fraction of 4X GAL-CLA4t cells with cortical Cla4myc18 staining remained below 1% throughout the time course. Right; 4X 
GAL-CLA4t cells expressing myc-tagged Ste20 (Ste20myc18, ySP3091) were grown in YEPR, arrested in G1 with  -factor, and then shifted to 
either YEPD (glu) or YEPRG (gal) medium containing  -factor for 2 h to maintain the G1 arrest. The fraction of cells displaying polarized 
localization of Ste20 was 55% in YEPD and 3% in YEPRG (n   100). Bar, 5  m. (G) Wild-type (W303), cla4  (ySP3076), ste20  (ySP3078), 
bub2  (ySP3138), bub2  cla4  (ySP3186), and bub2  ste20  (ySP3198) cells were grown in YEPD, shifted to YEPD containing nocodazole 
(t   0), and collected at the indicated times for FACS
® analysis of DNA contents. The percentage of re-replicating cells at each time point was 
calculated as described in Materials and methods. (H) Wild-type (ySP3157) and 4X GAL-CLA4t (ySP3202) cells expressing myc-tagged Hsl1 
were grown in YEPR, arrested in G1 with  -factor, and released in YEPRG. Samples were collected at different times for immunostaining of 
Hsl1myc18. Photographs were taken 90’ after release. Bar, 5  m.T
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CLA4t pheromone-treated G1 cells were released into the cell
cycle in the presence of both galactose and nocodazole. As
shown in Fig. 2, expression of CLA4t prevented a fraction of
Clb2 from being degraded, slightly delayed Sic1 accumulation
and prevented most mad2  cells from rebudding (Fig. 5 A)
and re-replicating (unpublished data). Deletion of SWE1 in
these conditions antagonized the effects of Cla4t, in that it ac-
celerated kinetics of Clb2 degradation and Sic1 accumulation
Figure 4. Expression of GAL-CLA4t delays degradation of Cdc20/APC substrates with a mechanism partially dependent on Swe1. Wild-type 
(ySP1969), 1X GAL-CLA4t (ySP3073), swe1  1X GAL-CLA4t (ySP3098), and CDC28
Y19F 1X GAL-CLA4t (ySP3074) cells expressing myc-tagged 
securin (Pds1myc18) were grown in YEPR, arrested in G1 with  -factor, and released in YEPRG (t   0). Samples were collected at the indicated 
times for Western blot analysis (A) to score nuclear division (B) and for FACS
® analysis of DNA contents (not depicted). 10  g/ml  -factor was 
added back to the cultures at t   110’.T
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Figure 5 continues on next page.
of mad2  GAL-CLA4t cells, although not to the levels ob-
served for mad2  cells (Fig. 5 A). Furthermore, mad2  swe1 
GAL-CLA4t rebudded and re-replicated only poorly in these
conditions, suggesting that Cla4t prevents Clb2 degradation
and re-replication in mad2  cells both by activating Swe1 and
through an additional mechanism. Again, we found that the
CDC28
Y19F allele had no major effect on either Clb2 and Sic1
protein levels (Fig. 5 A) or re-replication efficiency of mad2 
GAL-CLA4t cells (unpublished data). Because Mad2 and
Bub2 activate the spindle checkpoint via different pathways,
we then performed the same analysis on bub2  cells. As
shown in Fig. 5 B, knocking out Swe1 function in bub2 T
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GAL-CLA4t cells restored a checkpoint defect similar to that
of bub2  cells, in terms of Clb2 degradation, Sic1 re-accumu-
lation, and kinetics of rebudding, erasing completely the ef-
fects of Cla4t. Thus, Swe1 can cooperate with either the
Mad2- or the Bub2-dependent pathways in preventing exit
from mitosis. Moreover, the different effects of Cla4t on the
ability of mad2  and bub2  cells to enter a new cell cycle on
checkpoint activation suggest that Cla4t can inhibit mitotic
exit in at least two different ways, one dependent and another
independent on Swe1; mad2  cells would be susceptible to
both inhibitory mechanisms, whereas the lack of BUB2 antag-
onizes the Swe1-independent mechanism.
Figure 5. Swe1 is required for Cla4t-dependent stabilization of Clb2 in nocodazole-treated spindle checkpoint mutants. (A) 1X GAL-CLA4t 
(ySP2622), mad2  (ySP1070), mad2  1X GAL-CLA4t (ySP2752), mad2  swe1  1X GAL-CLA4t (ySP3145), and mad2  CDC28
Y19F 1X GAL-CLA4t 
(ySP3148) cells (A) or 1X GAL-CLA4t (2622), bub2  (ySP3138), bub2  1X GAL-CLA4t (ySP2626), and bub  swe1  1X GAL-CLA4t (ySP2726) 
cells (B) were grown in YEPR, arrested in G1 with  -factor, and released in YEPRG (t   0). Samples were collected at the indicated times for 
Western blot analysis of Clb2 and Sic1 and for FACS
® analysis of the DNA contents (not depicted). 10  g/ml  -factor was added back to the 
cultures at t   120’. Swi6 was used as loading control. Cyc, cycling cells.T
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PAK kinases contribute to proper MEN activation
Because Cla4t prevents mitotic exit when heavily overpro-
duced in wild-type cells or when cell cycle progression is par-
tially compromised by spindle checkpoint activation, we
wondered whether it could affect MEN activation. Indeed,
the temperature-sensitive men mutants cdc15–2 and cdc14–3
were more sensitive than wild type to expression of a single
copy of GAL-CLA4t at the permissive temperature (Fig. 6
A). Moreover, deletion of SWE1 did not rescue, but eventu-
ally accentuated, the lethality of cdc15–2 GAL-CLA4t and
cdc14–3 GAL-CLA4t cells on galactose-containing plates,
suggesting that Cla4t might directly affect MEN activation
independently of Swe1. In the attempt to correlate with spe-
cific cell cycle defects the poor tolerance of cdc15–2 and
cdc14–3 mutants to moderately high levels of Cla4t, we ar-
rested in G1 wild-type, cdc15–2, and cdc14–3 cells, either
carrying or lacking one copy of GAL-CLA4t, and followed
the appearance and disappearance of binucleate anaphase
cells on release from the G1 block in the presence of galac-
tose at 25 C. Although Cla4t did not seem to affect the ki-
netics of nuclear division, comparison of the kinetics of dis-
appearance of binucleate cells indicated that it delayed cell
division by  30 min in both cdc15–2 and cdc14–3 cells
(Fig. 6 B) independently of Swe1 (unpublished data), sug-
gesting that PAK kinases contribute to MEN activation un-
der these conditions. This is not achieved by promoting
Bfa1 phosphorylation, which in turn correlates with inhibi-
tion of Bfa1/Bub2 GAP activity (Hu et al., 2001) because
we found no major differences in the kinetics of Bfa1 phos-
phorylation between wild-type and swe1  GAL-CLA4t cells
(unpublished data). We then verified whether high levels of
Cla4t might displace and therefore inactivate Lte1, as wild-
type Cla4 has been recently implicated in the correct lo-
calization of the Tem1 activator Lte1 at the bud cortex
(Hofken and Schiebel, 2002; Seshan et al., 2002). Indeed,
overexpression of CLA4t in 4X GAL-CLA4t cells, where we
assume Cla4 and Ste20 are completely inactive, abolished
polarized Lte1 but not actin distribution at the bud cortex
(Fig. 6 C). Again, deletion of SWE1 did not reestablish
proper Lte1 localization (unpublished data). Expression of a
single copy of GAL-CLA4t slightly decreased the percentage
of small- and medium-size budded cells with polarized Lte1
(70% in small/medium budded GAL-CLA4t cells versus
90% of wild-type cells). Thus, moderately high levels of
Cla4t, although not completely inhibiting endogenous Cla4
and Ste20, might be sufficient to delay Tem1 activation at
the end of mitosis in cells whose MEN activity is partially
compromised. If partial Tem1 inactivation due to PAK ki-
nases inhibition were the only reason for the mitotic exit de-
lay caused by Cla4t in the absence of Swe1, one would pre-
dict that Tem1 activation could be rescued by eliminating
its GAP Bfa1/Bub2, thereby counteracting the effect of Lte1
displacement from the bud cortex. To test this notion, we
analyzed the effects of BUB2 deletion on cell cycle progres-
sion of swe1  4X GAL-CLA4t, which we previously showed
to be only partially able to exit mitosis (Fig. 3 A). Deletion
of BUB2 by its own had negligible effects on the cell cycle
block of galactose-induced 4X GAL-CLA4t cells, that ar-
rested with 2C DNA contents (Fig. 7 A), undivided nuclei
and metaphase spindles (Fig. 7 B). Strikingly, bub2  swe1 
4X GAL-CLA4t cells exited mitosis much faster than swe1 
4X GAL-CLA4t cells, entering a new round of DNA replica-
tion (Fig. 7 A) and disassembling their anaphase spindles
with nearly wild-type kinetics, thus accumulating as multi-
nucleate cells (Fig. 7 B). We obtained similar results by ana-
lyzing the effects of SWE1 and BUB2 deletion in the tem-
perature-sensitive cla4–75 ste20 double mutant (Cvrckova et
al., 1995), although Bub2 seemed to have a predominant
role over Swe1 in preventing mitotic exit at 37 C (unpub-
lished data). Therefore, PAK kinases appear to control MEN
activation by at least two different mechanisms; one operat-
ing at the metaphase to anaphase transition and that can be
inhibited by Swe1, and the other impinging more directly
on Tem1 activation.
Discussion
Inhibition of PAK kinases by Cla4t
We have shown that overexpression of the truncated domi-
nant-negative CLA4t allele prevents cell cycle progression of
nocodazole-treated spindle checkpoint mutants and causes a
mitotic arrest very reminiscent of the one reported for cla4
ste20 double mutants (Cvrckova et al., 1995). In fact, cells
have duplicated chromosomes, but fail to undergo nuclear
division and mitotic exit, and display a characteristic peanut-
shaped morphology due to their inability to form a proper
bud neck constriction in preparation to cytokinesis. This cor-
relates with a slight defect in assembling the septin ring, but
presumably other as yet unidentified cytokinetic processes are
also impaired. Importantly, polar localization of both endog-
enous Cla4 and Ste20 is disrupted in CLA4t-overexpressing
cells, and the in vitro kinase activity of immunoprecipitated
endogenous Cla4 is reduced under the same conditions. The
CLA4t gene product, which lacks part of the COOH-termi-
nal kinase domain, but still contains protein–protein interac-
tion motifs in the NH2-terminal part, might directly bind to
endogenous Cla4 and Ste20 and therefore inhibit them. In
fact, mammalian PAK kinases have been shown to dimerize
and autoinhibit in trans, with the NH2-terminal portion of
one subunit inhibiting the catalytic domain of the other (Par-
rini et al., 2002). Although immunoprecipitation assays did
not reveal physical interactions between wild-type Cla4 and
either itself or Ste20 (unpublished data), we cannot exclude
that interaction is labile and stabilized when Cla4t acts as a
partner in the dimers. Cla4t might also act by sequestering
Cdc42 in an inactive form, resulting in the lack of activation
of Cdc42 targets other than Cla4 and Ste20. If this were the
case, we would expect to alleviate the effects of Cla4t over-
production by replacing wild-type CDC42 with the cdc42
V36A
allele, which impairs more efficiently interaction of Cdc42
with Cla4 than with other effectors (Gladfelter et al., 2001),
and should therefore reduce the capacity of Cla4t to titrate
Cdc42 out, allowing it to activate other targets. Conversely,
we found that not only did the cdc42
V36A allele not restore the
ability to progress through the cell cycle in bub2  GAL-
CLA4t cells treated with nocodazole, but also decreased by its
own the ability of bub2  cells to re-replicate under these con-
ditions (Fig. S1, available at http://www.jcb.org/cgi/content/
fulljcb.200209097). In addition, concomitant overexpression
of CDC42 from the GAL1 promoter does not counteract theT
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Figure 6. GAL-CLA4t expression delays MEN activation and prevents proper localization of Lte1 at the bud cortex. (A) Serial dilutions of 
1X GAL-CLA4t (ySP2622), cdc14–3 (ySP284), cdc14–3 1X GAL-CLA4t (ySP3028), cdc14–3 swe1  1X GAL-CLA4t (ySP3047), cdc15–2 (ySP51), 
cdc15–2 1X GAL-CLA4t (ySP3022), and cdc15–2 swe1  1X GAL-CLA4t (ySP3023) strains were spotted on either YEPD ( Gal) or YEPRG 
( Gal) plates and incubated for 2 d at 26 C. (B) Wild-type, cdc15–2, and cdc14–3 cells either lacking (W303, ySP51, and ySP284) or carrying 
(ySP2622, ySP3022, and ySP3028) one copy of GAL-CLA4t were grown in YEPR, arrested in G1 with  -factor, and released in YEPRG (t   0). 
Samples were collected every 30’ for FACS
® analysis of the DNA contents (not depicted) and to score nuclear division. (C) Wild-type (ySP3222), 
1X GAL-CLA4t (ySP3220, not depicted), and 4X GAL-CLA4t (ySP3221) cells were treated as in B. Samples were collected every 15’ for 150’ 
for FACS
® analysis of the DNA contents (not depicted) and to score localization of GFP-Lte1 and actin by rhodamine-phalloidin. Photographs 
were taken 75’ after release. Bar, 5  m.T
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toxicity caused by high levels of Cla4t (unpublished data). It
is also worth noting that polarized actin distribution, which
is affected in cells lacking either functional Cdc42 (Adams et
al., 1990) or Cdc42 effectors other than Cla4 and Ste20,
such as Gic1 and Gic2 (Brown et al., 1997; Chen et al.,
1997), is not disrupted by either overexpression of Cla4t
(Fig. 6 C) or inactivation of both Cla4 and Ste20 (Cvrckova
et al., 1995). Therefore, we propose that even if Cla4t can se-
quester Cdc42, its effects on cell cycle progression might be
at least partially attributed to inhibition of wild-type Cla4
and Ste20. Consistently, we show that deletion of either
CLA4 or STE20 can reduce the fraction of bub2  cells that
re-replicate in the presence of nocodazole (Fig. 3 G). There-
fore, we think it is reasonable to assume that endogenous
Cla4 and Ste20 are inactive in cells overproducing Cla4t, al-
though we have not formally proven it.
PAK kinases and Swe1 regulate both the onset of 
anaphase and mitotic exit
In agreement with previous data (Longtine et al., 2000;
Weiss et al., 2000; Mitchell and Sprague, 2001), we have
shown that inactivation of Cla4 and Ste20 by Cla4t in-
duces a Swe1-dependent G2/M delay, whose extent de-
pends on Cla4t levels. This is likely the consequence
of morphogenesis checkpoint activation (Lew and Reed,
1995) caused by septin ring defects and mislocalization of
Hsl1 (Fig. 3, E and H), which normally targets Swe1 to
degradation (McMillan et al., 1999; Longtine et al., 2000).
Swe1 inactivates Clb1–4/Cdks by inhibitory phosphoryla-
tion of their catalytic subunit Cdc28 on tyrosine 19 (Boo-
her et al., 1993). How do Clb1–4/Cdc28 kinases bring
about the onset of anaphase? One process they definitely
regulate is spindle assembly because inactivation of all mi-
totic cyclin genes CLB1–4, as well as overexpression of
SWE1 or the presence of a CDC28 allele mimicking consti-
tutive tyrosine 19 phosphorylation, inhibit separation of
the duplicated SPBs and bipolar spindle assembly (Surana
et al., 1991; Fitch et al., 1992; Lim et al., 1996). However,
this is probably not the only anaphase mechanism con-
trolled by Clb1–4/Cdks. In fact, we have shown that Swe1
is responsible for stabilizing the securin Pds1 on moderate
CLA4t overexpression, when cells undergo normal cycles of
Figure 7. Bub2 and Swe1 act synergistically in regulating mitotic exit. 4X GAL-CLA4t (ySP2625), bub2  4X GAL-CLA4t (ySP2630), swe1  
4X GAL-CLA4t (ySP2711), and bub2  swe1  4X GAL-CLA4t (ySP2728) cells were grown in YEPR, arrested in G1 with  -factor, and released 
in YEPRG medium (t   0). Samples were collected at the indicated times for FACS
® analysis of DNA contents (A) and to follow kinetics of 
spindle assembly/disassembly by  -tubulin immunostaining (B). Photographs were taken 3 h after release. Bar, 5  m.T
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spindle assembly/disassembly. In addition, Swe1 protects a
fraction of Clb2 from degradation in spindle checkpoint
mutants treated with nocodazole, i.e., in conditions where
a spindle is not formed anyway. Both observations might
be explained if Swe1 had a role in controlling Cdc20/APC
activity. In fact, Cdc20/APC not only drives Pds1 (Visintin
et al., 1997; Lim et al., 1998) and a first wave of Clb2 deg-
radation (Baumer et al., 2000; Yeong et al., 2000; Wasch
and Cross, 2002), but Cdc28 kinase activity is also neces-
sary for full Cdc20/APC activation (Rudner et al., 2000;
Rudner and Murray, 2000). Therefore, Swe1, by phos-
phorylating Cdc28, might prevent proper Cdc20/APC-
dependent degradation of both Pds1 and Clb2, which is a
prerequisite for full MEN activation at the end of mito-
sis (Cohen-Fix and Koshland, 1999; Tinker-Kulberg and
Morgan, 1999; Yeong et al., 2000; Wasch and Cross,
2002). This hypothesis (depicted in Fig. 8) is consistent
with our finding that Cla4t can delay mitotic exit of men
mutants at permissive temperature and of nocodazole-
treated spindle checkpoint mutants through a mechanism
partially dependent on Swe1. Despite that the only known
target of Swe1 thus far is Cdc28, we observed only a minor
restoration of Clb2 degradation in cells expressing CLA4t
in the presence of the CDC28
Y19F allele, which relieves the
inhibitory function of Swe1. Thus, either Swe1 phosphory-
lates targets other than Cdc28, or Swe1-dependent inhibi-
tion of Clb2 proteolysis might still be mediated by Cdc28
phosphorylation, but we cannot properly see it because un-
phosphorylatable Cdc28 displays reduced kinase levels and
Cdc20/APC activity (Rudner et al., 2000). Because a
CDC28
T18VY19F allele impairs the physical association be-
tween Cdc20 and APC in a cdc15 telophase arrest (Rudner
et al., 2000), we also investigated whether the CDC28
Y19F
allele or overexpression of either SWE1 or CLA4t might
similarly affect Cdc20/APC interaction. We found no ma-
jor differences with a wild-type control (unpublished data),
suggesting that other mechanisms, like phosphorylation of
APC subunits, might influence the activity of the complex.
A reduced Cdc20/APC activity could also explain why ex-
pression of a single copy of GAL-CLA4t, which barely de-
lays the onset of anaphase in wild-type cells, can almost
completely prevent mad2  and bub2  mutants from over-
riding a checkpoint arrest. In fact, Cla4t-dependent inhibi-
tion of Cdc20/APC would counteract its activation due to
the lack of Mad2, thus reinforcing MEN inhibition oper-
ated by Bub2/Bfa1 (Fig. 8). Less intuitive is how reduced
Cdc20/APC activity could prevent bub2  and bfa1  cells
from exiting mitosis in the presence of nocodazole because
Cdc20 should be kept inactive by Mad2 and Mad3
(Hwang et al., 1998; Fraschini et al., 2001; Hoyt, 2001).
Remarkably, we have found that the ability of bub2  cells
to separate sister chromatids and re-replicate in nocodazole
requires Cdc20 function (Fig. S2), indicating that there
might exist a pool of Cdc20 refractory to inhibition by
Mad2 and Mad3.
Despite that the deletion of SWE1 accelerates Clb2 deg-
radation and mitotic exit in cells expressing GAL-CLA4t, it
does not rescue wild-type kinetics of mitotic exit either on
heavy overproduction of Cla4t or in nocodazole-treated
mad2  cells moderately overproducing Cla4t, suggesting
that inhibition of PAK kinases by Cla4t might prevent
MEN activation also by Swe1-independent means. We find
that overexpression of CLA4t prevents Lte1 cortical local-
ization, thus down-regulating the MEN, consistent with
the recent finding that Cla4 phosphorylates and targets
Lte1 to the bud cortex, thereby allowing timely activation
of Tem1 (Hofken and Schiebel, 2002; Seshan et al., 2002).
However, this cannot be the only level of MEN regulation
exerted by PAK kinases, as LTE1 is not essential at the tem-
peratures we performed our experiments (Adames et al.,
2001). Indeed, deletion of BUB2, that allows Tem1 activa-
tion in the absence of Lte1, although not sufficient by its
own to drive CLA4t overexpressing cells out of mitosis,
greatly stimulates mitotic exit of swe1  GAL-CLA4t cells,
indicating that SWE1 deletion and TEM1 activation act
synergistically to fully activate the MEN, as proposed in
Fig. 8. Interestingly, Hofken and Schiebel (2002) have re-
ported a role for Ste20 in MEN activation unrelated to Lte1
association with the bud cortex. An intriguing hypothesis
that would match our data is that Ste20 is implicated in
down-regulating Swe1, thereby allowing full activation of
Cdc20/APC at the onset of anaphase and the early release
of Cdc14 from the nucleolus.
Based on our data, the PAK kinases Cla4 and Ste20
might be considered new members of the MEN. Remark-
ably, the Schizosaccharomyces pombe septation initiation net-
work, which has similar organization to the MEN (Bardin
and Amon, 2001; McCollum and Gould, 2001), includes
the Sid1 PAK kinase (Guertin et al., 2000), and overexpres-
sion of the Sid1-interacting factor Cdc14 (unrelated to its
Saccharomyces cerevisiae namesake) causes a G2 arrest that
likely depends on the Swe1-like kinase Wee1 (Fankhauser
and Simanis, 1993).
Interdependency between mitotic exit and cytokinesis
In budding yeast, the site of cell division is already estab-
lished at the G1/S transition, concomitantly with bud emer-
Figure 8. A model for the role of PAK kinases in controlling 
mitotic progression. See text for details.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 PAK kinases regulate mitotic exit in yeast | Chiroli et al. 871
gence. During this process, the actin cytoskeleton undergoes
profound rearrangements, so that actin patches get concen-
trated at the tip of the bud and actin cables orient toward it.
At this cell cycle stage, the septin ring is also formed (Cooper
and Kiehart, 1996; Longtine et al., 1996) and a contractile
actomyosin ring starts assembling (Bi et al., 1998).
A dependency of cytokinesis on mitotic exit and inactiva-
tion of cyclinB/Cdks has long been established both in yeast
and in other eukaryotic systems (Field et al., 1999; Surana et
al., 2002). In addition, the requirement of Cdc20/APC-
dependent proteolysis for MEN activation dictates a hierar-
chical order of events, where nuclear division occurs before
mitotic exit, which is in turn a prerequisite for cytokinesis.
Our data lead to the unforeseen conclusion that cytokinetic
events can influence the kinetics of mitotic exit by allowing
full activation of Cdc20/APC and by promoting cortical lo-
calization of Lte1 (Fig. 8). In summary, to exit mitosis, two
conditions must be satisfied: (1) Cdc20/APC must be fully
active to promote Pds1 and the first wave of Clb1–4 degra-
dation. In fact, Pds1 inhibits the early release of Cdc14 from
the nucleolus (Stegmeier et al., 2002; Yoshida et al., 2002),
which together with the reduction in Clb/Cdks contributes
to activation of Cdc15, and in turn, Cdc14 itself (Jaspersen
and Morgan, 2000). Moreover, PAK and Clb1–4/Cdc28 ki-
nases, as well as extinction of checkpoint signals, are neces-
sary for complete activation of Cdc20/APC; and (2) nuclear
division must take place along the mother-bud axis, thus al-
lowing Tem1, which is localized at SPBs, to access Lte1 con-
Table I. Table of strains
Name Relevant genotype
ySP51 MATa, cdc15-2
ySP284 MATa, cdc14-3
ySP1070 MATa, mad2::TRP1
ySP1071 MATa, bub2::HIS3
ySP1086 MATa, mad2::TRP1, bub2::HIS3
ySP1243 MATa, bfa1::KlTRP1
ySP1969 MATa, pds1::PDS1-myc18::LEU2
ySP2457 MATa, cdc20::MET3::HA3-CDC20::TRP1, his3::HIS3::tetR-GFP, ura3::URA3::336XtetO
ySP2622 MATa, ura3::1X URA3::GAL1-CLA4t
ySP2623 MATa, ura3::2X URA3::GAL1-CLA4t
ySP2624 MATa, ura3::3X URA3::GAL1-CLA4t
ySP2625 MATa, ura3::4X URA3::GAL1-CLA4t
ySP2626 MATa, bub2::HIS3, ura3::1X URA3::GAL1-CLA4t
ySP2630 MATa, bub2::HIS3, ura3::4X URA3::GAL1-CLA4t
ySP2631 MATa, cdc20::MET3::HA3-CDC20::TRP1, bub2::HIS3, his3::HIS3::tetR-GFP, ura3::URA3::336XtetO
ySP2634 MATa, bub2::HIS3, his3::HIS3::tetR-GFP, ura3::URA3::336XtetO
ySP2711 MATa, swe1::LEU2, ura3::4X URA3::GAL1-CLA4t
ySP2726 MATa, bub2::HIS3, swe1::LEU2, ura3::1X URA3::GAL1-CLA4t
ySP2728 MATa, bub2::HIS3, swe1::LEU2, ura3::4X URA3::GAL1-CLA4t
ySP2752 MATa, mad2::TRP1, ura3::1X URA3::GAL1-CLA4t
ySP3022 MATa, cdc15-2, ura3::1X URA3::GAL1-CLA4t
ySP3023 MATa, cdc15-2, swe1::LEU2, ura3::1X URA3::GAL1-CLA4t
ySP3028 MATa, cdc14-3, ura3::1X URA3::GAL1-CLA4t
ySP3047 MATa, cdc14-3, swe1::LEU2, ura3::1X URA3::GAL1-CLA4t
ySP3068 MATa, mad2::TRP1, bub2::HIS3, ura3::1X URA3::GAL1-CLA4t
ySP3073 MATa, ura3::1X URA3::GAL1-CLA4t, pds1::PDS1-myc18::LEU2
ySP3074 MATa, cdc28::CDC28
Y19F, ura3::1X URA3::GAL1-CLA4t, pds1::PDS1-myc18::LEU2
ySP3076 MATa, cla4::kanMX4
ySP3078 MATa, ste20::kanMX4
ySP3086 MATa, cla4::CLA4-myc18::KlTRP1
ySP3088 MATa, cla4::CLA4-myc18::KlTRP1, ura3::4X URA3::GAL1-CLA4t
ySP3091 MATa, ste20::STE20-myc18::KlTRP1, ura3::4X URA3::GAL1-CLA4t
ySP3098 MATa, swe1::LEU2, ura3::1X URA3::GAL1-CLA4t, pds1::PDS1-myc18::LEU2
ySP3138 MATa, bub2::HIS3
ySP3145 MATa, mad2::TRP1, swe1::LEU2, ura3::1X URA3::GAL1-CLA4t
ySP3148 MATa, mad2::TRP1, cdc28::CDC28
Y19F, ura3::1X URA3::GAL1-CLA4t
ySP3157 MATa, hsl1::HSL1-myc18::KlTRP1
ySP3186 MATa, bub2::HIS3, cla4::kanMX4
ySP3198 MATa, bub2::HIS3, ste20::kanMX4
ySP3202 MATa, ura3::4X URA3::GAL1-CLA4t, hsl1::HSL1-myc18::KlTRP1
ySP3220 MATa, ura3::1X URA3::GAL1-CLA4t, kanMX6::GAL1-GFP-LTE1
ySP3221 MATa, ura3::4X URA3::GAL1-CLA4t, kanMX6::GAL1-GFP-LTE1
ySP3222 MATa, kanMX6::GAL1-GFP-LTE1T
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strained in the bud (Bardin et al., 2000; Pereira et al., 2000)
with a mechanism dependent on Cla4 (Hofken and Schie-
bel, 2002; Seshan et al., 2002; this work). Alternatively, in-
hibition of Bub2/Bfa1 by Cdc5 is sufficient to allow Tem1
activation (Adames et al., 2001; Hu et al., 2001). Such an
intricate network of controls would guarantee the correct or-
der of mitotic events and the dependency of mitotic exit on
both nuclear division and cytokinesis. This latter feature
might play a particularly relevant role in organisms like bud-
ding yeast, which specify the site of cytokinesis early in the
cell cycle, before spindle assembly and orientation. Interest-
ingly, a checkpoint control involving both Wee1 and the
septation initiation network monitors proper accomplish-
ment of early cytokinetic events in fission yeast (Liu et al.,
2000), suggesting that it might be a common feature in eu-
karyotic cells.
Materials and methods
Strains, media, and reagents
All yeast strains (Table I) were derivatives of or were back-crossed at least
three times to W303 (ade2–1, trp1–1, leu2–3,112, his3–11,15, ura3, ssd1),
except for ySP3220, ySP3221, and ySP3222, which are congenic with
each other. Cells were grown in YEP medium (1% yeast extract, 2% bac-
topeptone, 50 mg/l adenine) supplemented with 2% glucose (YEPD), 2%
raffinose (YEPR), or 2% raffinose and 1% galactose (YEPRG). Unless other-
wise stated,  -factor, nocodazole, and benomyl were used at 2  g/ml, 15
 g/ml, and 12.5  g/ml, respectively. Synchronization experiments were
performed at 25 C, and unless otherwise stated, galactose was added half
an hour before release from  -factor.
Screen for high copy number suppressors of bub2 
A leu2 bub2  mutant (ySP1071) was transformed with a genomic library
constructed in the LEU2 YEp13 2  plasmid (from K. Nasmyth, Institute of
Molecular Pathology, Vienna, Austria). 26,000 Leu
  transformants were
replica-plated twice on YEPD plates containing benomyl 20  g/ml. Plas-
mids were recovered from benomyl-resistant clones and used to transform
again the original bub2  strain. Sequencing of both junctions of the inserts
of 48 plasmids that confirmed suppression allowed to group them into 23
different classes. We then transformed with one plasmids for each class the
tub2–405 mutant (Huffaker et al., 1988), whose benomyl sensitivity is due
to defective  -tubulin. Plasmids increasing the benomyl resistance of
tub2–405 cells were discarded, thus leaving eight plasmids specifically
rescuing the benomyl sensitivity of bub2  cells.
Plasmid constructions and genetic manipulations
Standard techniques were used for genetic manipulations (Sherman, 1991;
Maniatis et al., 1992). Wild-type and truncated CLA4 were amplified by
PCR from genomic DNA and subcloned in the BamHI site of Yep13, to
generate pSP150 and pSP164, respectively. To clone CLA4t under the
GAL1–10 promoter (plasmid pSP176) a BglII PCR product containing the
CLA4t coding region was cloned in the BamHI site of a GAL1–10-bearing
YIplac211 vector. pSP176 integration was directed to the URA3 locus by
ApaI digestion. Copy number of the integrated plasmid was verified by
Southern analysis. CLA4 and STE20 chromosomal deletions were gener-
ated by one-step gene replacement (Wach et al., 1994). CLA4, STE20,
HSL1, and BFA1 were tagged immediately before the stop codon by one-
step gene tagging (Knop et al., 1999). The GAL-GFP-LTE1 construct
(Pereira et al., 2002) is a gift from E. Schiebel (The Paterson Institute for
Cancer Research, Manchester, UK). The cdc42
V36A, swe1::LEU2, and tub2-
405 mutants were provided by D. Lew (Duke University Medical Center,
Durham, NC), M.L. Agostoni Carbone (Dipartimento di Genetica, Milano,
Italy), and T. Huffaker (Cornell University, Ithaca, NY), respectively.
Immunoprecipitations, kinase assays, and Western blot analysis
Cla4-myc18 was immunoprecipitated from 1 mg of total extract by protein
A-sepharose beads cross-linked to anti-myc antibodies, and kinase assays
were performed as described previously (Benton et al., 1997). For Western
blot analysis, protein extracts were prepared according to Surana et al.
(1993). Proteins transferred to Protran
® membranes (Schleicher and
Schuell) were probed with 9E10 mAb for myc-tagged Pds1, and with pAbs
against Clb2, Sic1, and Swi6. Anti-Clb2 and anti-Sic1 antibodies were pro-
vided by W. Zachariae (Max Planck Institute of Molecular Cell Biology,
Dresden, Germany) and M. Tyers (Department of Molecular and Medical
Genetics, Toronto, Canada), respectively. Secondary antibodies were pur-
chased from Amersham Biosciences, and proteins were detected by an
ECL system according to the manufacturer.
Other techniques
Flow cytometric DNA quantitation was determined according to Fraschini
et al. (1999) on a Becton Dickinson FACScan™. Due to a dramatic cyto-
kinetic defect caused by CLA4 deletion in our genetic background, it was
hard to distinguish on the FACS
® histograms the fraction of cla4  cells
that displayed DNA contents higher than 2C due to the ability to re-repli-
cate in the presence of nocodazole from the fraction of multinucleate
cells resulting from a cytokinesis failure. Therefore, the values plotted in
Fig. 3 G were obtained by subtracting at each time point the percentage
of microscopically scored cell clusters from the percentage of cells with
DNA contents higher than 2C measured with CELLQuest™ software. Nu-
clear division was scored with a fluorescent microscope on cells stained
with propidium iodide. In situ immunofluorescence was performed
according to Fraschini et al. (1999). Immunostaining of  -tubulin was
performed with the YOL34 mAb (Serotec) followed by indirect immuno-
fluorescence using rhodamine-conjugated anti–rat Ab (1:100; Pierce Chem-
ical Co.). Immunostaining of Cla4myc18, Ste20myc18, and Hsl1myc18
was detected by incubation with the 9E10 mAb followed by indirect im-
munofluorescence using CY3-conjugated goat anti–mouse Ab (1:500;
Amersham Biosciences). Detection of Cdc3-GFP and Lte1-GFP was per-
formed on ethanol-fixed cells, on wash with water and sonication. Cells
were similarly fixed to stain actin with 20 U/ml rhodamine-phalloidin
(Sigma-Aldrich). Digital images were taken with a CCD camera and soft-
ware (CoolSNAP; Photometrics).
Online supplemental material
Supplemental figures correspond to Figs. S1 and S2. Online supplemental
material available at http://www.jcb.org/cgi/content/fulljcb.200209097.
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